tirzepatide user reviews (Mounjaro) — Weight Loss Results Oral tirzepatide for flexible weight-loss

Month-over-month ADM prescribing increased from December 2024 to January 2025, then remained relatively stable until March 2025

Moreover, 89% to 91% of patients lost 5% or more of their weight, which is considered clinically significant for improving metabolic health

If your home remained at or below 86F, many clinicians believe the medication remains viable, though its total shelf life may be shortened

Well-rounded meals with lean proteins, vegetables, and whole grains ensure you dont feel the need to snack while still respecting the fullness that retatrutide can induce

This is due to its ability to suppress appetite and slow digestion